TAKEDA AIMS TO GO PUBLIC IN THE NEXT 5 TO 10 YEARS AFTER BLACKSTONE’S ACQUISITION

Highlights –

• Takeda Pharmaceutical aims to go public in the next 5 to 10 years after Blackstone’s acquisition.
• The unit needs to expand its business overseas in Chinese-speaking markets.
• Takeda plans to sell its drug unit to Blackstone for $2.3 billion.
• The sale is expected to be completed by the end of March next year.

Japan’s Takeda Pharm....